2009Majallah-i taḥqīqāt-i dāmpizishkī-i īrānRequires access

Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration

Priyanshee Gohil, Urvesh D. Patel, Shailesh K. Bhavsar, A. M. Thaker

Open publisher page 9 citations

Abstract

Summary Pharmacokinetics of ceftriaxone was studied in buffalo calves (Bubalus bubalis) after single intravenous and intramuscular administration of 10 mg/kg body weight. The drug concentrations in plasma samples were measured by high performance liquid chromatography with UV detection. Following intravenous administration, the drug was rapidly distributed (Cp o : 106.5 ± 9.64 µg/ml; t1/2α: 0.09 ± 0.01 h; Vdarea: 0.48 ± 0.05 L/kg) and eliminated (t1/2β: 1.27 ± 0.04 h) from the body with a clearance rate of 4.40 ± 0.44 ml/min.kg. Following intramuscular administration, the peak plasma concentration of the drug was 15.8 ± 2.4 µg/ml at 0.5 h and the drug was detected up to 12 h. The drug was rapidly absorbed from the site of injection (t1/2ka: 0.35 ± 0.01 h), widely distributed (Vdarea: 1.53 ± 0.2 L/kg) and slowly eliminated from the body (t1/2β: 4.38 ± 0.4 h; ClB: 4.01 ± 0.30 ml/min.kg). The bioavailability of ceftriaxone was 70.2 ± 2.0% following intramuscular injection. Intramuscular injection of ceftriaxone has favourable pharmacokinetics and moderate bioavailability in buffalo calves and can be used for susceptible infections in calves.

About this research paper

What this paper is about

Summary Pharmacokinetics of ceftriaxone was studied in buffalo calves (Bubalus bubalis) after single intravenous and intramuscular administration of 10 mg/kg body weight. The drug concentrations in plasma samples were measured by high performance liquid chromatography with UV detection. Following intravenous administration, the drug was rapidly distributed (Cp o : 106.5 ± 9.64 µg/ml; t1/2α: 0.09 ± 0.01 h; Vdarea: 0.48 ± 0.05 L/kg) and eliminated (t1/2β: 1.27 ± 0.04 h) from the body with a clearance rate of 4.40 ± 0.44 ml/min.kg. Following intramuscular administration, the peak plasma concentration of the drug was 15.8 ± 2.4 µg/ml at 0.5 h and the drug was detected up to 12 h. The drug was rapidly absorbed from the site of injection (t1/2ka: 0.35 ± 0.01 h), widely distributed (Vdarea: 1.53 ± 0.2 L/kg) and slowly eliminated from the body (t1/2β: 4.38 ± 0.4 h; ClB: 4.01 ± 0.30 ml/min.kg). The bioavailability of ceftriaxone was 70.2 ± 2.0% following intramuscular injection. Intramuscular injection of ceftriaxone has favourable pharmacokinetics and moderate bioavailability in buffalo calves and can be used for susceptible infections in calves.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Summary Pharmacokinetics of ceftriaxone was studied in buffalo calves (Bubalus bubalis) after single intravenous and intramuscular administration of 10 mg/kg body weight. The drug concentrations in plasma samples were measured by high performance liquid chromatography with UV detection. Following intravenous administration, the drug was rapidly distributed (Cp o : 106.5 ± 9.64 µg/ml; t1/2α: 0.09 ± 0.01 h; Vdarea: 0.48 ± 0.05 L/kg) and eliminated (t1/2β: 1.27 ± 0.04 h) from the body with a clearance rate of 4.40 ± 0.44 ml/min.kg. Following intramuscular administration, the peak plasma concentration of the drug was 15.8 ± 2.4 µg/ml at 0.5 h and the drug was detected up to 12 h. The drug was rapidly absorbed from the site of injection (t1/2ka: 0.35 ± 0.01 h), widely distributed (Vdarea: 1.53 ± 0.2 L/kg) and slowly eliminated from the body (t1/2β: 4.38 ± 0.4 h; ClB: 4.01 ± 0.30 ml/min.kg). The bioavailability of ceftriaxone was 70.2 ± 2.0% following intramuscular injection. Intramuscular injection of ceftriaxone has favourable pharmacokinetics and moderate bioavailability in buffalo calves and can be used for susceptible infections in calves.

Key concepts: Pharmacokinetics, Ceftriaxone, Bubalus, Bioavailability, Intramuscular injection, Medicine, Drug administration, Cmax

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of ceftriaxone in buffalo calves (Bubalus bubalis) following intravenous and intramuscular administration — Research Paper | ScholarLens